Guardian Pharmacy Services, Inc. Class A GRDN 深 滬
已收盤 02-06 16:00:00 美东时间
33.88
+1.010
+3.07%
華盛通- 最 高33.97
- 今 開33.00
- 成交量 13.83万股
- 最 低 32.34
- 昨 收 32.87
- 總市值 21.45亿
- 52周最高 37.43
- 市盈率 靜 --
- 換手率 0.22%
- 52周最低 17.78
- 委 比 50.38%
- 總股本 6332.06万
- 歷史最高 37.43
- 量 比 0.52
- 振 幅 4.96%
- 歷史最低 14.16
- 每 手 1
- 風險率 4.04%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 英特尔、美光科技、SanDisk等获大行上调目标价；纽约梅隆银行获5家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Rezolve AI"买入"评级，目标价从10美元升至12美元；HC Wainwright & Co.：维持Largo"买入"评级，目标价从2.9美元升至3.1美元
01-15 16:10
Guardian Pharmacy Services Reiterates Its Previously Announced 2025 Revenue Guidance Of $1.43B To $1.45B; For 2026, Co. Expects Revenue In The Range Of $1.40B To $1.42B
Guardian Pharmacy Services (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, is reiterating its previously announced 2025 guidance and providing its preliminary financial
01-14 05:33
美股大行评级 | 花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级
花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>
2025-11-17 10:49
Guardian Pharmacy Service shares are trading higher after the company reported Q3 earnings and revenue above estimates and raised its FY2025 sales guidance.
Guardian Pharmacy Service shares are trading higher after the company reported ...
2025-11-11 22:38
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
2025-11-10 19:12
Guardian Pharmacy Locks Up Majority of Shares
Guardian Pharmacy Services, Inc. Class A ( ($GRDN) ) has provided an announceme...
2025-10-15 05:19
美股大行评级 | 伯恩斯坦上调阿里巴巴目标价升至200美元；麦格理上调百度评级至"跑赢大市"，目标价升至176美元
今日重点评级关注：摩根大通：维持National Energy Services"超配"评级，目标价从10美元升至19美元；Piper Sandler：维持LENZ Therapeutics"超配"评级，目标价从51美元升至67美元
2025-10-13 11:26
Oppenheimer Initiates Coverage On Guardian Pharmacy Service with Outperform Rating, Announces Price Target of $30
Oppenheimer analyst Michael Wiederhorn initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) with a Outperform rating and announces Price Target of $30.
2025-10-11 01:49
美股大行评级 | 潜在涨幅485.44%！Allarity Therapeutics获机构升目标价至9.25美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Allarity Therapeutics"买入"评级，目标价从9美元升至9.25美元；JMP证券：维持Crinetics Pharmaceuticals"跑赢大市"评级，目标价从86美元升至143美元
2025-09-29 09:15
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $30
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE: GRDN) with a Buy and raises the price target from $28 to $30.
2025-09-26 23:19
